乙酰肝素酶与糖尿病性肾病的相关性研究进展
摘要
糖尿病性肾病(diabetic nephropathy,DN)是糖尿病患者的重要死因,同时又是导致肾功能衰竭的一个重要疾病。早期诊断DN,有利于提高糖尿病患者的生存率、生活质量,减少国家的医疗负担。目前尚缺乏更优于尿微量白蛋白的检测指标,
出处
《实用临床医学(江西)》
CAS
2011年第10期137-139,共3页
Practical Clinical Medicine
参考文献23
-
1Hook M,Wasteson A,Oldberg A. A heparan sulfate degrading endoglycosidase from rat liver tissue[J]. Biochem Biophys Res Commun, 1975,67(4) : 1422-1428.
-
2Freeman C,Parish C R. A rapid quantitative assay for the de tection of mammalian heparanase activity[J]. Biochem J, 1997, 32:229 237.
-
3Vlodavsky I,Friedmann Y, Elkin M, et al. Mammalian hepara- nasc:gene cloning, expression and function in tumor progres sion and metastasis[J]. Nat Med, 1999,5 (7): 793-802.
-
4Hulel M D, Freeman C, Hamdori B J, el al. Cloning of mamma lian heparanase, an important enzyme in tumor invasion and met aslasis[J]. Nat Med, 1999,5 (7) : 803-809.
-
5Toyoshima M, Nakajima M. Human heparanase[J]. J Biol Chem, 1999,274 (34) :2413-2416.
-
6l.evy Adam F, Miao H Q, Heinrikson R L, et al. Heterodimer formation is essential for heparanase enzymatic activity [J ]. Biochem Biophys Res Commun, 2003,308 ( 4 ):885-891.
-
7Marchctti D, Reiland J, Erwin B, et al, Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin ana- logues[J]. Int J Cancer,2003,104(2) :167-174.
-
8van den Hoven M J, Rops A L, Bakker M A, et al. Increased expression of heparanase in overt diabetic ncphropathy[J]. Kidney Int,2006,70(12) :2100-2108.
-
9Levidiotis V,Kanellis J, lerino F l.,et al. Increased expression of heparanase in puromycin aminonucleoside nephrosis[J]. Kidney Int,2001,60(4) :1287-1296.
-
10Katz A, Van Dijk B J, Aingorn H, et al. Involvement of hu-- man heparanase in the patbogenesis of diabetic nepbropathy [J]. Isr Med Assoc J,2002,4(11) :996-1002.
二级参考文献7
-
1Conde-Knape K. Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications. Diabetes Metab Res Rev, 2001, 17: 412-421.
-
2Vlodavsky I, Friedmann Y, Elkin M, et al. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med, 1999, 5: 793-802.
-
3Jeansson M, Haraldsson B. Glomerular size and charge selectivity in the mouse after exposure to glycosaminoglycandegrading enzymes. J Am Soc Nephrol, 2003, 14: 1756- 1765.
-
4Maxhimer JB, Somenek M, Rao G, et al. Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes, 2005, 54: 2172- 2178
-
5van den Hoven MJ, Rops AL, Bakker MA, et al. Increased expression of heparanase in overt diabetic: nephropathy. Kidney Int, 2006, 70: 2100-2108.
-
6Wijnhoven TJ, den Hoven M J, Ding H, et al. Heparanase induces a difterential loss of heparan sulphate domains in overt diabetic nephropathy. Diabetologia, 2008, 51: 372-382.
-
7唐琳,王玉华,刘章锁,肖静,窦艳娜,董吉.乙酰肝素酶在糖尿病肾病大鼠蛋白尿发生中的作用[J].中华肾脏病杂志,2008,24(4):277-281. 被引量:4
-
1洪洋懿,阳学风.乙酰肝素酶在脂肪肝中的表达[J].美国中华临床医学杂志,2004,6(1):16-17.
-
2段景琪,吕肖锋.血清乙酰肝素酶在糖尿病并发急性冠脉综合征中的变化及临床意义[J].中国实用内科杂志,2009,29(10):933-934. 被引量:1
-
3王玉华,唐琳,秦林燕,刘章锁.糖尿病肾病大鼠肾组织乙酰肝素酶的基因表达及意义[J].中国医药指南,2013,11(34):347-348.
-
4唐琳,王玉华,刘章锁,肖静,窦艳娜,董吉.乙酰肝素酶在糖尿病肾病大鼠蛋白尿发生中的作用[J].中华肾脏病杂志,2008,24(4):277-281. 被引量:4
-
5刘艳秋,解长银,王志伟,李红林.糖尿病合并冠心病患者血清乙酰肝素酶水平变化及意义[J].重庆医学,2017,46(3):396-398. 被引量:16
-
6秦林燕,刘章锁.替米沙坦对糖尿病肾病大鼠蛋白尿的影响[J].河南职工医学院学报,2009,21(1):1-3. 被引量:1
-
7赵越,安晓飞,余江毅.血清乙酰肝素酶与2型糖尿病血管病变的相关性分析[J].实用医学杂志,2010,26(18):3317-3319. 被引量:1
-
8赵越,余江毅,安晓飞.血清乙酰肝素酶与2型糖尿病代谢性指标的相关性研究[J].中国全科医学,2011,14(17):1893-1895. 被引量:2
-
9杜江涛,王建生,赵瑛瑛,刘东伟,杜倩.舒洛地特对糖尿病肾病大鼠肾脏乙酰肝素酶及碱性成纤维细胞生长因子表达影响[J].中华实用诊断与治疗杂志,2011,25(3):253-254. 被引量:1
-
10杨玉捷,张方信,赵春林,姜丽,葛勤利,钟世顺,张亚历.乙酰肝素酶在溃疡性结肠炎肠黏膜中的表达及在致病机制中的作用[J].中华消化杂志,2005,25(2):67-70. 被引量:2